Trial intelligence / Profile preview

Propranolol Adjuvant Treatment of Bladder Cancer

NCT04493489Phase 2Unknown

Sponsor
Central South University
Start
Sep 2020
Primary completion
Sep 2023
Modality
Small Molecules
01

Overview

A Phase 2 trial of propranolol in bladder cancer, sponsored by Central South University. Status: unknown.

02

Drugs

propranolol
03

Conditions

bladder cancer

Beyond the preview

Go deeper on NCT04493489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04493489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call